MALT lymphoma

For patient information, click here

MALT lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating MALT Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

MRI

Endoscopic Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

MALT lymphoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of MALT lymphoma

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMALT lymphoma

CDC on MALT lymphoma

MALT lymphoma in the news

on MALT lymphoma

Directions to Hospitals Treating MALT lymphoma

Risk calculators and risk factors for MALT lymphoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Sujit Routray, M.D. [3], Ahmed Younes M.B.B.CH [4]

Synonyms and keywords: Mucosal-associated lymphoid tissue lymphoma; Extranodal marginal zone B-cell lymphoma; Gastrointestinal lymphoma; MALT; Mucosa associated lymphoid tissue (MALT) lymphoma; MALToma; Lymphoma of mucosa associated lymphoid tissue; MALT-type lymphoma; Gut-associated lymphoid tissue (GALT); Bronchial/tracheal-associated lymphoid tissue (BALT); Nose-associated lymphoid tissue (NALT); Vulvovaginal-associated lymphoid tissue (VALT), Extranodal marginal zone of lymphoma of mucosa-associated lymphoid tissue

## Overview

[edit | edit source]

## Historical Perspective

[edit | edit source]

## Classification

[edit | edit source]

## Pathophysiology

[edit | edit source]

## Causes

[edit | edit source]

## Differentiating MALT Lymphoma from other Diseases

[edit | edit source]

## Epidemiology and Demographics

[edit | edit source]

## Risk Factors

[edit | edit source]

## Screening

[edit | edit source]

## Natural History, Complications and Prognosis

[edit | edit source]

## Diagnosis

[edit | edit source]

Staging | History and Symptoms | Physical Examination | Laboratory Findings | Upper GI Endoscopy | CT | MRI | Endoscopic Ultrasound | Biopsy | Other Imaging Findings | Other Diagnostic Studies

## Treatment

[edit | edit source]

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

## Case Studies

[edit | edit source]

Case #1

* v
* t
* e

Myeloid Hematological malignancy/leukemia histology (ICD-O 9590-9989, C81-C96, 200-208)

CFU-GM/
and other granulocytes|

Template:Navbox subgroup

MEP|

Template:Navbox subgroup

CFU-Mast|

Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis)

Multiple/unknown|

AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) * MP (Myelofibrosis) * Acute biphenotypic leukaemia

See also hematology, lymphoid malignancy

de:MALT-Lymphom

Template:WikiDoc Sources
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template